[HTML][HTML] Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants

SH Kanuri, RP Kreutz - Journal of personalized medicine, 2019 - mdpi.com
Direct oral anticoagulants (DOAC) have shown an upward prescribing trend in recent years
due to favorable pharmacokinetics and pharmacodynamics without requirement for routine …

International consensus statement on the peri‐operative management of direct oral anticoagulants in cardiac surgery

G Erdoes, B Martinez Lopez De Arroyabe… - …, 2018 - Wiley Online Library
Despite current recommendations on the management of severe peri‐operative bleeding,
there is no pragmatic guidance for the peri‐operative monitoring and management of …

Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination

S Lee, KK Sankhala, S Bose… - … Medical Case Reports …, 2022 - Taylor & Francis
Purpose To report a case of combined central retinal vein and artery occlusion that evolved
into ischemic optic neuropathy following the Pfizer COVID-19 vaccination. Methods Patient …

Progress of mesenchymal stem cell-derived exosomes in tissue repair

G Zhao, Y Ge, C Zhang, L Zhang, J Xu… - Current …, 2020 - ingentaconnect.com
Mesenchymal stem cells (MSCs) are a kind of adult stem cells with self-replication and
multidirectional differentiation, which can differentiate into tissue-specific cells under …

Emerging pharmacotherapeutic approaches for the management of sickle cell disease

L Torres, N Conran - Expert opinion on pharmacotherapy, 2019 - Taylor & Francis
Introduction: Sickle cell disease (SCD) is an inherited disease with lifelong morbidity, whose
complications include frequent acute painful vaso-occlusive episodes (VOEs) that often …

The selectivity and bioavailability improvement of novel oral anticoagulants: An overview

Z Xie, Y Tian, X Lv, X Xiao, M Zhan, K Cheng… - European Journal of …, 2018 - Elsevier
Anticoagulants have exhibited a critical role in the prevention and/or treatment of thrombotic
diseases. Up to now, kinds of novel oral anticoagulants, inhibiting plasma serine proteases …

Use of direct oral anticoagulants in ICU patients. Part I–Applied pharmacology

A Wahab, R Patnaik, M Gurjar - Anaesthesiology Intensive Therapy, 2021 - termedia.pl
Direct oral anticoagulants (DOACs) have revolutionized the field of anticoagulation in the
last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non …

Prevalence and predictors of inappropriate apixaban dosing in patients with non-valvular atrial fibrillation at a large tertiary academic medical institution

HA Badreldin, L Alreshoud, R Altoukhi… - Drugs & Therapy …, 2020 - Springer
Objectives The aim of this study was to assess apixaban prescribing practices for stroke
prevention in patients with non-valvular atrial fibrillation (NVAF), and to examine the factors …

Direct-Acting Oral Anticoagulants.

EP Inocian - Medsurg Nursing, 2020 - search.ebscohost.com
Direct-acting oral anticoagulants (DOACs) are among the most common medications
administered by clinical medical-surgical nurses. Proactive measures and targeted patient …

Nicht Vitamin-K-abhängige orale Antikoagulanzien (NOAK)

J Koscielny - Klinische Angiologie, 2023 - Springer
Im Wesentlichen werden NOAK zur Prophylaxe und Therapie thromboembolischer
Erkrankungen angewendet. Der gerinnungshemmende Effekt beruht auf der direkten …